WELLELL INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.8 TWD | +0.36% |
|
+1.28% | -3.81% |
| 18/03 | Wellell Inc. Appoints Su Ya-Ling as Chief Operating Officer | CI |
| 15/03 | Wellell Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Sales 2022 | 2.66B 81.76M 6.82B | Sales 2023 | 2.65B 81.25M 6.77B | Capitalization | 2.92B 89.52M 7.46B |
|---|---|---|---|---|---|
| Net income 2022 | 161M 4.94M 412M | Net income 2023 | 152M 4.67M 389M | EV / Sales 2022 | 1.1 x |
| Net cash position 2022 | 50.01M 1.53M 128M | Net cash position 2023 | 395M 12.12M 1.01B | EV / Sales 2023 | 0.95 x |
| P/E ratio 2022 |
18.5
x | P/E ratio 2023 |
19.3
x | Employees | - |
| Yield 2022 |
2.89% | Yield 2023 |
-
| Free-Float | 64.77% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +0.36% | ||
| 1 week | +1.28% | ||
| Current month | -2.11% | ||
| 1 month | -1.94% | ||
| 3 months | +0.54% | ||
| 6 months | +2.77% | ||
| Current year | -3.81% |
1 week
27.50
28.00
1 month
27.3028.90
Current year
27.1529.05
1 year
26.4539.75
3 years
22.7553.00
5 years
16.3053.00
10 years
16.3066.20
| Managers | Title | Age | Since |
|---|---|---|---|
Heng Wei Chen
CEO | Chief Executive Officer | - | 25/19/25 |
Shih Ho Chen
DFI | Director of Finance/CFO | - | 24/15/24 |
Yung Chuan Li
CHM | Chairman | 54 | 17/90/17 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Kuo Cheng Wang
BRD | Director/Board Member | - | 18/13/18 |
Yung Chuan Li
CHM | Chairman | 54 | 17/90/17 |
Chang Chi Liu
BRD | Director/Board Member | - | 14/10/14 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 27.8 | +0.36% | 76,371 |
| 25/24/25 | 27.7 | 0.00% | 54,167 |
| 24/24/24 | 27.7 | -0.36% | 102,126 |
| 23/24/23 | 27.8 | +0.91% | 56,373 |
| 22/24/22 | 27.55 | +0.36% | 85,951 |
End-of-day quote Taiwan S.E., April 26, 2024
More quotes
Wellell Inc, formerly Apex Medical Corp, is a Taiwan-based company principally engaged in the manufacture, trading, import and export of medical and healthcare related equipment. The main products include the wound management (WM) series, respiratory therapy (RT) series, welfare equipment, as well as the electronic medical devices (EMD) series, such as four-wheel walk helpers, crutches, wheelchairs, shower devices, automatic positive airway pressure (APAP) devices, interferential stimulators, electrical muscle stimulators (EMSs) and liquid crystal display (LCD) massage devices. The Company mainly distributes products to Europe, the Americas and Asia.
Calendar
01/05/2024
- Q1 2024 Earnings Release (Projected)
Chiffre d''affaires - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -3.81% | 86M | |
| -3.41% | 9.4B | |
| +30.20% | 1.92B | |
| -3.90% | 1.39B | |
| -7.38% | 1.18B | |
| -18.42% | 857M | |
| +0.48% | 470M | |
| +3.62% | 437M | |
| -49.68% | 360M | |
| -24.72% | 333M |
- Stock Market
- Equities
- 4106 Stock
